1. Biologic therapy had minimal additional benefits for patients compared to triple therapy. 2. When used as a first-line therapy, ...
Osimertinib or platinum-pemetrexed in EGFR T790M-positive lung cancer First line treatment for patients with advanced, non-small cell lung cancers that ...
1. Baricitinib, an oral, once-daily inhibitor of JAK1 and JAK2, has shown promise in the treatment of rheumatoid arthritis (RA). ...
1. The addition of a non-TNF-targeted biologic therapy is superior to the addition of an anti-TNF biologic therapy in patients ...
1. Patients who developed rheumatoid arthritis (RA) were less likely to have had a gastrointestinal (GI) or genitourinary (GU) infection ...
Originally published by Harvard Health. What Is It? Rheumatoid arthritis is a chronic (long-lasting) inflammatory disease that causes pain, stiffness, warmth, ...
1. At 6 months, patients receiving tofacitinib monotherapy had reduced structural joint damage compared to methotrexate monotherapy. 2. Patients treated ...
Image: PD 1. Patients with rheumatoid arthritis (RA) taking tofacitinib in combination with non-biologic disease-modifying antirheumatic drugs (DMARDs) demonstrated an ...
Image: PD In this section, we will highlight the key high-impact studies, updates, and analyses published in medicine during the ...
Image: CC/James Heilman Primer: Rheumatoid factors (RF) are autoantibodies directed against the Fc portion of immunoglobulin. Serum IgM RF occurs ...
